Cysteinyl Leukotriene Signaling Aggravates Myocardial Hypoxia in Experimental Atherosclerotic Heart Disease

• Elena Nobili,

  Affiliations Monzino Cardiologic Center, IRCCS, Milan, Italy, Department of Pharmacology, University of Milan, Milan, Italy

  ⨯
• M. Dolores Salvado,

  Affiliation Department of Medical Biochemistry (MBB) II, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Lasse Folkersen,

  Affiliation Department of Medicine, Exp. Cardiovascular Research, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Laura Castiglioni,

  Affiliation Department of Pharmacology, University of Milan, Milan, Italy

  ⨯
• Jens Kastrup,

  Affiliation Department of Cardiology B, Cardiac Catheterization Laboratory, Rigshospitalet, Copenhagen, Denmark

  ⨯
• Anders Wetterholm,

  Affiliation Department of Medical Biochemistry (MBB) II, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Elena Tremoli,

  Affiliations Monzino Cardiologic Center, IRCCS, Milan, Italy, Department of Pharmacology, University of Milan, Milan, Italy

  ⨯
• Göran K. Hansson,

  Affiliation Department of Medicine, Exp. Cardiovascular Research, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Luigi Sironi,

  Affiliations Monzino Cardiologic Center, IRCCS, Milan, Italy, Department of Pharmacology, University of Milan, Milan, Italy

  ⨯
• Jesper Z. Haeggström ,

  * E-mail: jesper.haeggstrom@ki.se (JZH); anders.gabrielsen@ki.se (AG)

  Affiliation Department of Medical Biochemistry (MBB) II, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Anders Gabrielsen

  * E-mail: jesper.haeggstrom@ki.se (JZH); anders.gabrielsen@ki.se (AG)

  Affiliation Department of Medicine, Exp. Cardiovascular Research, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

  ⨯